Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/h7OVBdI0umk/253096.php
Thursday, 22 November 2012
New Data Demonstrate Reduction In Opioid Use, Hospital Cost And Length Of Stay With EXPAREL� As The Foundation Of A Multimodal Regimen
Results published in the Journal of Pain Research compare cost of care between standard opioid-based regimen and EXPAREL-based multimodal regimen for postsurgical pain management Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that results from the first IMPROVE study to complete its prospective Phase 4 clinical program were published in the online version of the Journal of Pain Research...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment